First human test of Virus-Targeting cancer treatment begins
NCT ID NCT05707910
Summary
This is an early safety study testing a new immunotherapy for people with advanced cancers linked to the Epstein-Barr virus (EBV), such as certain lymphomas and nasopharyngeal carcinoma. The trial involves 6 adults whose cancer has progressed despite standard treatments. Researchers are primarily checking if the new treatment is safe while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.